Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion type Assertion NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_head.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion description "[The well-known associations between CYP2R1 (rs1993116, rs10741657), GC (rs2282679), and DHCR7 (rs7944926, rs12785878) genotypes and 25(OH)D3 serum levels were also apparent in patients with chronic hepatitis C. The same genotypes of these single nucleotide polymorphisms (SNPs) that are associated with reduced 25(OH)D3 serum levels were found to be associated with HCV-related HCC (P?=?0.07 [OR?=?1.13, 95% CI?=?0.99-1.28] for CYP2R1, P?=?0.007 [OR?=?1.56, 95% CI?=?1.12-2.15] for GC, P?=?0.003 [OR?=?1.42, 95% CI?=?1.13-1.78] for DHCR7; ORs for risk genotypes).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_provenance.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion evidence source_evidence_literature NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_provenance.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion SIO_000772 23734184 NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_provenance.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion wasDerivedFrom befree-2016 NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_provenance.
- NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_assertion wasGeneratedBy ECO_0000203 NP1083181.RAVaBOiV56blYKzYpLAquHwvawSFkylGDpoVAMxQQ5kPE130_provenance.